181 related articles for article (PubMed ID: 37716616)
1. Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ).
Fromme M; Hamesch K; Schneider CV; Mandorfer M; Pons M; Thorhauge KH; Pereira V; Sperl J; Frankova S; Reichert MC; Benini F; Burbaum B; Kleinjans M; Amzou S; Rademacher L; Bewersdorf L; Verbeek J; Nevens F; Genesca J; Miravitlles M; Nuñez A; Schaefer B; Zoller H; Janciauskiene S; Waern J; Oliveira A; Maia L; Simões C; Mahadeva R; Fraughen DD; Trauner M; Krag A; Lammert F; Bals R; Gaisa NT; Aigner E; Griffiths WJ; Denk H; Teumer A; McElvaney NG; Turner AM; Trautwein C; Strnad P
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):283-294.e5. PubMed ID: 37716616
[TBL] [Abstract][Full Text] [Related]
2. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
[TBL] [Abstract][Full Text] [Related]
3. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.
Hamesch K; Mandorfer M; Pereira VM; Moeller LS; Pons M; Dolman GE; Reichert MC; Schneider CV; Woditsch V; Voss J; Lindhauer C; Fromme M; Spivak I; Guldiken N; Zhou B; Arslanow A; Schaefer B; Zoller H; Aigner E; Reiberger T; Wetzel M; Siegmund B; Simões C; Gaspar R; Maia L; Costa D; Bento-Miranda M; van Helden J; Yagmur E; Bzdok D; Stolk J; Gleiber W; Knipel V; Windisch W; Mahadeva R; Bals R; Koczulla R; Barrecheguren M; Miravitlles M; Janciauskiene S; Stickel F; Lammert F; Liberal R; Genesca J; Griffiths WJ; Trauner M; Krag A; Trautwein C; Strnad P;
Gastroenterology; 2019 Sep; 157(3):705-719.e18. PubMed ID: 31121167
[TBL] [Abstract][Full Text] [Related]
4. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
Clark VC; Marek G; Liu C; Collinsworth A; Shuster J; Kurtz T; Nolte J; Brantly M
J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687
[TBL] [Abstract][Full Text] [Related]
5. Non-Invasive Assessment and Management of Liver Involvement in Adults With Alpha-1 Antitrypsin Deficiency.
Hamesch K; Strnad P
Chronic Obstr Pulm Dis; 2020 Jul; 7(3):260-271. PubMed ID: 32697896
[TBL] [Abstract][Full Text] [Related]
6. Alpha1-antitrypsin deficiency: New therapies on the horizon.
Remih K; Amzou S; Strnad P
Curr Opin Pharmacol; 2021 Aug; 59():149-156. PubMed ID: 34256305
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency.
Fromme M; Schneider CV; Pereira V; Hamesch K; Pons M; Reichert MC; Benini F; Ellis P; H Thorhauge K; Mandorfer M; Burbaum B; Woditsch V; Chorostowska-Wynimko J; Verbeek J; Nevens F; Genesca J; Miravitlles M; Nuñez A; Schaefer B; Zoller H; Janciauskiene S; Abreu N; Jasmins L; Gaspar R; Liberal R; Macedo G; Mahadeva R; Gomes C; Schneider KM; Trauner M; Krag A; Gooptu B; Thorburn D; Marshall A; Hurst JR; Lomas DA; Lammert F; Gaisa NT; Clark V; Griffiths W; Trautwein C; Turner AM; McElvaney NG; Strnad P
Gut; 2022 Feb; 71(2):415-423. PubMed ID: 33632708
[TBL] [Abstract][Full Text] [Related]
8. [Alpha-1 antitrypsin deficiency: cause and cofactor for liver disease].
Burbaum B; Fromme M; Strnad P
Dtsch Med Wochenschr; 2021 Jun; 146(11):714-718. PubMed ID: 34062584
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin.
Pérez-Luz S; Lalchandani J; Matamala N; Barrero MJ; Gil-Martín S; Saz SR; Varona S; Monzón S; Cuesta I; Justo I; Marcacuzco A; Hierro L; Garfia C; Gomez-Mariano G; Janciauskiene S; Martínez-Delgado B
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569847
[TBL] [Abstract][Full Text] [Related]
10. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
Barjaktarevic I; Miravitlles M
BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
[TBL] [Abstract][Full Text] [Related]
11. Mild Iron Overload as Seen in Individuals Homozygous for the Alpha-1 Antitrypsin Pi*Z Variant Does Not Promote Liver Fibrogenesis in
Guldiken N; Hamesch K; Schuller SM; Aly M; Lindhauer C; Schneider CV; Fromme M; Trautwein C; Strnad P
Cells; 2019 Nov; 8(11):. PubMed ID: 31717526
[TBL] [Abstract][Full Text] [Related]
12. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
Turner AM; Stolk J; Bals R; Lickliter JD; Hamilton J; Christianson DR; Given BD; Burdon JG; Loomba R; Stoller JK; Teckman JH
J Hepatol; 2018 Aug; 69(2):378-384. PubMed ID: 29572094
[TBL] [Abstract][Full Text] [Related]
13. Fazirsiran for Liver Disease Associated with Alpha
Strnad P; Mandorfer M; Choudhury G; Griffiths W; Trautwein C; Loomba R; Schluep T; Chang T; Yi M; Given BD; Hamilton JC; San Martin J; Teckman JH
N Engl J Med; 2022 Aug; 387(6):514-524. PubMed ID: 35748699
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder.
Fromme M; Schneider CV; Trautwein C; Brunetti-Pierri N; Strnad P
J Hepatol; 2022 Apr; 76(4):946-958. PubMed ID: 34848258
[TBL] [Abstract][Full Text] [Related]
15. The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.
Schmid ST; Koepke J; Dresel M; Hattesohl A; Frenzel E; Perez J; Lomas DA; Miranda E; Greulich T; Noeske S; Wencker M; Teschler H; Vogelmeier C; Janciauskiene S; Koczulla AR
Int J Chron Obstruct Pulmon Dis; 2012; 7():687-96. PubMed ID: 23055718
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency.
Karatas E; Raymond AA; Leon C; Dupuy JW; Di-Tommaso S; Senant N; Collardeau-Frachon S; Ruiz M; Lachaux A; Saltel F; Bouchecareilh M
JHEP Rep; 2021 Aug; 3(4):100297. PubMed ID: 34151245
[TBL] [Abstract][Full Text] [Related]
17. Clinical considerations in individuals with α
McElvaney GN; Sandhaus RA; Miravitlles M; Turino GM; Seersholm N; Wencker M; Stockley RA
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32165400
[TBL] [Abstract][Full Text] [Related]
18. Liver disease progression in patients with alpha-1 antitrypsin deficiency and protease inhibitor ZZ genotype with or without lung disease.
Wu T; Hagiwara M; Gnass E; Barman H; Sasson D; Treem W; Ren K; Marins EG; Karki C; Malhi H
Aliment Pharmacol Ther; 2023 Nov; 58(10):1075-1085. PubMed ID: 37718576
[TBL] [Abstract][Full Text] [Related]
19. Association between circulating alpha-1 antitrypsin polymers and lung and liver disease.
Núñez A; Belmonte I; Miranda E; Barrecheguren M; Farago G; Loeb E; Pons M; Rodríguez-Frías F; Gabriel-Medina P; Rodríguez E; Genescà J; Miravitlles M; Esquinas C
Respir Res; 2021 Sep; 22(1):244. PubMed ID: 34526035
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
